NRL Capital key facts
- NRL Capital is a other based in Beijing, China with 13 tracked portfolio companies.
- Notable positions include Zenitar Biomedical, Micot, Revelyx Bio.
About NRL Capital
NRL Capital is a direct investment firm based in Beijing, China. Established in 2020, NRL is an investment and fund management platform that combines domestic and international resources. The firm operates across fund of funds, direct investments, and secondary private equity, using both RMB and USD capital. The firm focuses on sectors such as healthcare, new infrastructure, advanced manufacturing, industrial internet, enterprise services, and consumer technology. The assets are managed by the executive management team.
NRL Capital portfolio at a glance
13 portfolio companies are on record for NRL Capital, including Zenitar Biomedical, Micot and Revelyx Bio.
3 of the 13 carry a recorded valuation.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 13 recorded positions
- ·Watchlist + alerts for NRL Capital's activity
Portfolio
13 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Zenitar Biomedical | — | ▮ | ▮ | ▮ |
| Micot | — | ▮ | ▮ | ▮ |
| Revelyx Bio | — | ▮ | ▮ | ▮ |
+ 10 more companies · all 13, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Frequently asked about NRL Capital
- What companies does NRL Capital invest in?
- NRL Capital has 13 recorded portfolio companies, including Zenitar Biomedical, Micot, Revelyx Bio.